Same-Day PrEP Initiation and Sexual Health for Transgender Women
This randomized trial will evaluate the feasibility and acceptability of same day initiation of Tenofovir Alafenamide PrEP, evaluate impact of drug-level feedback on PrEP adherence and characterize PrEP persistence among transgender women in Uganda. Funding is provided through Gilead Sciences.
Countries
Active Dates
09/01/2020 to 08/31/2023
Faculty Involved
Health Topics